Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Gains from Sales and Divestitures (2022 - 2025)

Milestone Scientific's Gains from Sales and Divestitures history spans 4 years, with the latest figure at $337081.0 for Q3 2025.

  • For Q3 2025, Gains from Sales and Divestitures fell 33.97% year-over-year to $337081.0; the TTM value through Sep 2025 reached $337081.0, down 33.97%, while the annual FY2024 figure was $693106.0, 0.22% changed from the prior year.
  • Gains from Sales and Divestitures for Q3 2025 was $337081.0 at Milestone Scientific, roughly flat from $337081.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $694658.0 in Q4 2023 and bottomed at $173443.0 in Q1 2024.
  • The 4-year median for Gains from Sales and Divestitures is $337081.0 (2025), against an average of $387783.6.
  • The largest annual shift saw Gains from Sales and Divestitures soared 140.23% in 2023 before it plummeted 39.29% in 2024.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $449695.0 in 2022, then soared by 54.47% to $694658.0 in 2023, then dropped by 0.22% to $693106.0 in 2024, then crashed by 51.37% to $337081.0 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Gains from Sales and Divestitures are $337081.0 (Q3 2025), $337081.0 (Q2 2025), and $182584.0 (Q1 2025).